CA2262469C - Utilisation de polypeptides wnt - Google Patents

Utilisation de polypeptides wnt Download PDF

Info

Publication number
CA2262469C
CA2262469C CA002262469A CA2262469A CA2262469C CA 2262469 C CA2262469 C CA 2262469C CA 002262469 A CA002262469 A CA 002262469A CA 2262469 A CA2262469 A CA 2262469A CA 2262469 C CA2262469 C CA 2262469C
Authority
CA
Canada
Prior art keywords
cells
wnt
cell
polypeptide
wnt polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002262469A
Other languages
English (en)
Other versions
CA2262469A1 (fr
Inventor
William Matthews
Timothy W. Austin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/696,566 external-priority patent/US5851984A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CA2262469A1 publication Critical patent/CA2262469A1/fr
Application granted granted Critical
Publication of CA2262469C publication Critical patent/CA2262469C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002262469A 1996-08-16 1997-08-07 Utilisation de polypeptides wnt Expired - Lifetime CA2262469C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/696,566 1996-08-16
US08/696,566 US5851984A (en) 1996-08-16 1996-08-16 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
PCT/US1997/013910 WO1998006747A2 (fr) 1996-08-16 1997-08-07 Utilisation de polypeptides wnt

Publications (2)

Publication Number Publication Date
CA2262469A1 CA2262469A1 (fr) 1998-02-19
CA2262469C true CA2262469C (fr) 2005-11-22

Family

ID=35475126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002262469A Expired - Lifetime CA2262469C (fr) 1996-08-16 1997-08-07 Utilisation de polypeptides wnt

Country Status (1)

Country Link
CA (1) CA2262469C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824885A1 (fr) * 2006-10-20 2021-05-26 Children's Medical Center Corporation Procédé pour améliorer la régénération tissulaire
WO2017132494A1 (fr) * 2016-01-28 2017-08-03 The Board Of Trustees Of The Leland Stanford Junior University Compositions wnt et procédés de synthèse de celles-ci sans sérum

Also Published As

Publication number Publication date
CA2262469A1 (fr) 1998-02-19

Similar Documents

Publication Publication Date Title
AU721947B2 (en) Uses for WNT polypeptides
US6159462A (en) Uses of Wnt polypeptides
JP5525770B2 (ja) Ｗｓｘレセプター及びリガンド類
EP0848755B2 (fr) Proteine apparentee au vegf
EP0815224B1 (fr) Activation de recepteurs au moyen du gene 6 specifique de l'arret de croissance (gas6)
EP0888385B1 (fr) Recepteur de gdnf et son utilisation
US20110136223A1 (en) Neurturin receptor
HUT75657A (en) Thrombopoietin
US7074397B1 (en) Method for enhancing proliferation or differentiation of a cell using ob protein
CA2281620C (fr) Recepteur de la neurturine
US7524937B2 (en) WSX receptor agonist antibodies
CA2262469C (fr) Utilisation de polypeptides wnt
US6541604B1 (en) Leptin receptor having a WSX motif
KR100607613B1 (ko) 트롬보포이에틴
KR20040065249A (ko) 트롬보포이에틴

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170807